Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 Apr;40(4):673–683. doi: 10.1172/JCI104300

STUDIES ON THE ACTIVATION OF A SERUM ESTERASE WITH ETHER AND ITS RELATIONSHIP TO C′1-ESTERASE*

Virginia H Donaldson 1,2
PMCID: PMC290773  PMID: 13723696

Full text

PDF
673

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. xi-Aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem. 1959 Apr;234(4):832–837. [PubMed] [Google Scholar]
  2. BAUMGARTEN W., CIMINERA J. L., COLE R. B. Assay procedure for the quantitative determination of clot lysis activity. Vox Sang. 1960 Sep;5:416–424. doi: 10.1111/j.1423-0410.1960.tb05219.x. [DOI] [PubMed] [Google Scholar]
  3. BECKER E. L. Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl fluophosphate. J Immunol. 1956 Dec;77(6):462–468. [PubMed] [Google Scholar]
  4. BECKER E. L. Concerning the mechanism of complement action. II. The nature of the first component of guinea pig complement. J Immunol. 1956 Dec;77(6):469–478. [PubMed] [Google Scholar]
  5. Christensen L. R. METHODS FOR MEASURING THE ACTIVITY OF COMPONENTS OF THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM, AND STREPTOCOCCAL DESOXYRIBONUCLEASE. J Clin Invest. 1949 Jan;28(1):163–172. doi: 10.1172/JCI102045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DONALDSON V. H. Effect of plasmin in vitro on clotting factors in plasma. J Lab Clin Med. 1960 Oct;56:644–651. [PubMed] [Google Scholar]
  7. KLEIN P. G. Studies on immune hemolysis: preparation of a stable and highly reactive complex of sensitized erythrocytes and the first component of complement (EAC'1): inactivation of cell-fixed C'1 by some complement reagents. J Exp Med. 1960 Jan 1;111:77–91. doi: 10.1084/jem.111.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LEPOW I. H., PILLEMER L. Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. II. Demonstration of two distinct reaction stages in complement fixation. J Immunol. 1955 Jul;75(1):63–70. [PubMed] [Google Scholar]
  9. LEPOW I. H., RATNOFF O. D., LEVY L. R. Studies on the activation of a proesterase associated with partially purified first component of human complement. J Exp Med. 1958 Mar 1;107(3):451–474. doi: 10.1084/jem.107.3.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LEPOW I. H., RATNOFF O. D., PILLEMER L. Elution of an esterase from antigen-antibody aggregates treated with human complement. Proc Soc Exp Biol Med. 1956 May;92(1):111–114. doi: 10.3181/00379727-92-22401. [DOI] [PubMed] [Google Scholar]
  11. LEPOW I. H., ROSS A. Studies on immune cellular injury. II. Functional role of C'1 esterase in immune cytotoxicity. J Exp Med. 1960 Dec 1;112:1107–1120. doi: 10.1084/jem.112.6.1107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LEPOW I. H., WURZ L., RATNOFF O. D., PILLEMER L. Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++. J Immunol. 1954 Sep;73(3):146–158. [PubMed] [Google Scholar]
  13. LEVY L. R., LEPOW I. H. Assay and properties of serum inhibitor of C'l-esterase. Proc Soc Exp Biol Med. 1959 Aug-Sep;101:608–611. doi: 10.3181/00379727-101-25034. [DOI] [PubMed] [Google Scholar]
  14. NORMAN P. S. Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum. J Exp Med. 1957 Sep 1;106(3):423–437. doi: 10.1084/jem.106.3.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. OWREN P. A., AAS K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest. 1951;3(3):201–208. doi: 10.3109/00365515109060600. [DOI] [PubMed] [Google Scholar]
  16. PILLEMER L., RATNOFF O. D., BLUM L., LEPOW I. H. The inactivation of complement and its components by plasmin. J Exp Med. 1953 Apr;97(4):573–589. doi: 10.1084/jem.97.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pillemer L., Ecker E. E. THE TERMINOLOGY OF THE COMPONENTS OF COMPLEMENT. Science. 1941 Nov 7;94(2445):437–437. doi: 10.1126/science.94.2445.437. [DOI] [PubMed] [Google Scholar]
  18. RATNOFF O. D., COLOPY J. E. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955 Apr;34(4):602–613. doi: 10.1172/JCI103109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. RATNOFF O. D., LEPOW I. H. Some properties of an esterase derived from preparations of the first component of complement. J Exp Med. 1957 Aug 1;106(2):327–343. doi: 10.1084/jem.106.2.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. SHERRY S., TROLL W. The action of thrombin on synthetic substrates. J Biol Chem. 1954 May;208(1):95–105. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES